Columbia Care Inc. Overview
Industry: Drug Manufacturers—Specialty & Generic
Sector: Healthcare
Columbia Care Inc. engages in cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was founded in 2012 and is headquartered in New York, New York.
Columbia Care Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Columbia Care Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Columbia Care Inc. Competitors
Columbia Care Inc. operates in the Drug Manufacturers—Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans